{"id":"NCT02654769","sponsor":"Actavis Inc.","briefTitle":"A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis","officialTitle":"Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato速 Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-02","primaryCompletion":"2015-09","completion":"2015-09","firstPosted":"2016-01-13","resultsPosted":"2020-05-12","lastUpdate":"2020-05-12"},"enrollment":441,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratosis"],"interventions":[{"type":"DRUG","name":"Ingenol Mebutate (Picato速)","otherNames":["Picato"]},{"type":"DRUG","name":"Generic Ingenol Mebutate","otherNames":[]},{"type":"DRUG","name":"Vehicle Foam","otherNames":["Placebo"]}],"arms":[{"label":"Active Comparator Picato速","type":"ACTIVE_COMPARATOR"},{"label":"Generic Ingenol Mebutate","type":"EXPERIMENTAL"},{"label":"Vehicle Foam","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study was to evaluate the safety and therapeutic equivalence of generic ingenol mebutate gel, 0.05% to Picato gel, 0.05% and to establish the superiority of the efficacy of these two products over the vehicle gel in the treatment of Actinic Keratosis (AK) on the trunk or extremities.","primaryOutcome":{"measure":"Primary Efficacy Outcome Measure","timeFrame":"8 weeks","effectByArm":[{"arm":"Active Comparator Picato速","deltaMin":50,"sd":null},{"arm":"Generic Ingenol Mebutate","deltaMin":49,"sd":null},{"arm":"Vehicle Foam","deltaMin":8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":20},"locations":{"siteCount":22,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":149},"commonTop":["Application site pain","Application site erosion","Application site pruritus","Upper respiratory tract infection","Muscle strain"]}}